Folic Acid and Neural Tube Defects Effective Primary Prevention or Wishful Thinking? Bengt Källén Monograph Series Avid Science Monograph Series Monograph Folic Acid and Neural Tube Defects: Effective Primary Prevention or Wishful Thinking? Bengt Källén* Tornblad Institute, Lund University, Sweden *Corresponding Author: Bengt Källén, Tornblad Institute, Lund University, Galjevångsvägen 26, SE-224 65 Lund, Swe- den, Tel: +46-46-222 7536; Email: [email protected] First Published July 20, 2017 Copyright: © 2017 Bengt Källén. This article is distributed under the terms of the Creative Com- mons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source. Statements and opinions expressed in the book are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of infor- mation contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book. 2 www.avidscience.com Avid Science Monograph Series Contents Preface Chapter 1: Neural tube defects Chapter 2: Genes and neural tube defects. The role of folic acid metabolism. Chapter 3: Different approaches to influence neural tube defect rates with folic acid or other vitamins: Gen- eral comments. Chapter 4: Efforts to influence the risk of recurrence of neural tube defects with folic acid. Chapter 5: Efforts to affect occurrence risk of neural tube defects with folic acid. Chapter 6: Effects of food fortification with folic acid. Chapter 7: Summary and concluding remarks. www.avidscience.com 3 Avid Science Monograph Series Preface Numerous hazards during pregnancy are known or suspect- ed, causing pregnancy complications, miscarriage, congeni- tal malformations, stillbirths, neonatal deaths, or neonatal or long term morbidity of the child. The degree of certainty in these causalities vary from generally accepted risks like that associated with maternal use of some anticonvulsants or abuse of alcohol to statements of associations which have so far not been verified by high quality independent data. On the contrary rather few external factors have been ascribed a beneficial effect on pregnancy outcome. Pre- pregnancy and early pregnancy care has been said to reduce complications which is definitely the case for women with diseases like diabetes but is more uncertain for normal, healthy women. The most wide-spread idea is the positive effect of folic acid on pregnancy outcome, notably on the rate of neural tube defects in the offspring. As we will see in this book, the idea grew from observations on differences in the rate of such malformations according to maternal social class. Many alternative explanations to such an association can be suggested but the main line of thought which was followed was nutrition and notably inadequate amounts of vitamins, among them folic acid, one of the many factors which are necessary for a normal embryonic development. Accumulating evidence supporting this association increased the conviction that folic acid was the ultimate answer to the prevention of neural tube defects, some other congeni- tal malformations, and pregnancy complications. Studies pointing in another direction were usually disregarded. It has resulted in a general recommendation that women who plan 4 www.avidscience.com Avid Science Monograph Series pregnancy should take extra folic acid and in many countries to food fortification with folic acid. The majority of people including the majority of scientists and health administrators are convinced about the beneficial effect of folic acid (e.g., 1). This does not necessarily mean that this is true. We can remember the general “knowledge” that it was beneficial to put the young infant on its stomach until it was proved that this habit increased the risk of sud- den infant death and the recommendation had resulted in a substantial number of such deaths around the world. For this reason I think it is necessary to scrutinize the avail- able evidence that folic acid actually reduces the risk of neural tube defects. Is this at all true and, if so, is it valid for all populations or only for some special ones, e.g., those with a high background rate of the malformations? This is what I have tried to do in the present book. Lund, May 2017 Bengt Källén Professor emeritus in embryology Reference: 1. Viswanathan M, Treiman KA, Dolo JK, Middleton JC, Coker.Schwimmer EJL, et al. Folic acid supplementation for the prevention of neural tube defects: an updated evidence report and systematic review for the US Pre- ventive Services Task Force. JAMA. 2017; 317: 190-203. No financial support was obtained for the preparation of this book. The author declares no conflict of interest. www.avidscience.com 5 Avid Science Monograph Series Chapter 1 Neural Tube Defects 6 www.avidscience.com Avid Science Monograph Series Abstract The basic neural tube defect rate varies between pop- ulations and races within populations, possibly mainly be- cause of genetics. There are marked temporal changes in neural tube defect rate. There is a significantly increased recurrence rate after a neural tube defect occurrence, varying in strength with the population rate of the defect. Relatively few non-genetic factors are definitively shown to affect the neural tube defect rate. In areas with large so- cioeconomic differences, there is an association between a low such level and an increased neural tube defect rate. Neural tube defects consist of three main types, some- times occurring together: anencephaly, spina bifida, and encephalocele. They are all serious malformations. The rate of anencephaly and spina bifida is usually about the same while encephalocele is rarer. Anencephaly means absence of brain – but the basal structures remain and mainly the hemispheres are miss- ing (Figure 1:1). If an infant is born with anencephaly it has a short life expectancy, survival beyond two weeks is rare. Other malformations often also exist. In one study, 25% had another unrelated malformation [1]. The true rate may be higher because the anencephaly is such a dominating malformation that other less impressive mal- formations may go unnoticed or be neglected. www.avidscience.com 7 Avid Science Monograph Series Figure 1:1: Stillborn infant with anencephaly and a closure defect of the upper spinal cord [2]. Encephalocele consists of a midline defect of the skull through which brain tissue and meninges are herniated, often in the occipital region. It is usually skin-covered and is often combined with a reduced head size with mi- crocephaly (Figure 1:2). The infant may survive but will often become mentally subnormal and have neurological sequels. The condition may be part of a genetic syndrome, 8 www.avidscience.com Avid Science Monograph Series Meckel-Gruber syndrome, with polycystic kidneys. This condition is autosomal recessive with 25% recurrence risk in a future pregnancy. Encephalocele is often combined with other malformations. In one study over 40% had an- other unrelated malformation [1]. Figure 1:2: Newborn infant with a large encephalocele and micro- cephaly [2]. www.avidscience.com 9 Avid Science Monograph Series Spina bifida consists of a dorsal defect of the spine with protruding meninges and often spinal cord (Figure 1:3). In most cases (over 90%) it is a myelomeningocele with the spinal cord herniated – other forms are menin- gocele or lipomeningocele where the spinal cord may be intact. It may be located anywhere along the spine but the most common location is in the lower spine. The defect can be surgically closed (even prenatally) but remaining neurological sequels are common and hydrocephaly may develop and also foot deformities as a result of nerve dam- ages. Figure 1:3: Newborn infant with spina bifida. Note positional defects of foot [2]. 10 www.avidscience.com
Description: